TB Research

Negative outcome in cutaneous Mycobacterium marinum infection treated with surgical intervention: Two-case report

Bo Sang, Xiujiao Xia, Ze‐Hu Liu

Medicine · 2024-10

Abstract

RATIONALE: Mycobacterium marinum (M marinum), a slow-growing nontuberculous mycobacterium (NTM), is widely distributed in aquatic environments. It is a well-known cutaneous pathogen, which causes sporotrichosis-like lesions. PATIENT CONCERNS: In this report, we describe 2 cases of subcutaneous M marinum infection. Both patients underwent several surgical procedures at local hospitals, and despite optimal surgical site healing, new lesions appeared in adjacent sites. DIAGNOSES: Based on NTM culture, identification by gene sequencing, and matrix-assisted laser desorption ionization time-of-flight mass spectrometry, the diagnosis of subcutaneous NTM infection was confirmed. INTERVENTIONS: The patients were treated with oral rifampicin 0.45 g/day and clarithromycin 1 g/day and oral doxycycline hydrochloride capsules (200 mg/day), respectively. OUTCOMES: Both patients were treated for 8 and 5 weeks, respectively, and the lesions healed. LESSONS: Surgical debridement cannot compete with or impede NTM lymphatic spread; antimicrobial therapy is the first choice for the treatment of M marinum infections.

MeSH terms

  • Medicine
  • Mycobacterium marinum
  • Mycobacterium Infections
  • Outcome (game theory)
  • Intervention (counseling)
  • Surgery